Detalles de la búsqueda
1.
Monitoring of SARS-CoV-2 Infection in Ragusa Area: Next Generation Sequencing and Serological Analysis.
Int J Mol Sci
; 24(5)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902172
2.
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.
J Cell Mol Med
; 26(9): 2520-2528, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355397
3.
High Dickkopf-1 levels are associated with chronic inflammation in children with sickle cell disease.
Eur J Haematol
; 108(4): 336-341, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962669
4.
Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values.
Ann Hematol
; 99(9): 2047-2055, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32691114
5.
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
Blood Cells Mol Dis
; 69: 82-89, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29107441
6.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27748513
7.
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Am J Hematol
; 97(2): E75-E78, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861054
8.
Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Eur J Haematol
; 97(4): 361-70, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26818147
9.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24992281
10.
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Front Med (Lausanne)
; 9: 832154, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372393
11.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21599433
12.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Br J Haematol
; 145(2): 245-54, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236376
13.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Blood Cells Mol Dis
; 42(3): 247-51, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19233692
14.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Orphanet J Rare Dis
; 14(1): 120, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31146777
15.
Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.
Transfus Apher Sci
; 32(3): 315-21, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15908276
16.
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network.
JACC Cardiovasc Imaging
; 13(5): 1284-1286, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32061556
17.
The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.
Blood Transfus
; 11(3): 377-84, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23736930
18.
Use of an identification system based on biometric data for patients requiring transfusions guarantees transfusion safety and traceability.
Blood Transfus
; 7(3): 193-203, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19657483
Resultados
1 -
18
de 18
1
Próxima >
>>